Fresenius

Akorn's CEO bows out after failing last-ditch bid to save Fresenius merger
Akorn's CEO bows out after failing last-ditch bid to save Fresenius merger
Fierce Pharma
Akorn
Fresenius
M&A
Flag link:
Akorn fights to salvage Fresenius deal in appeal to Delaware Supreme Court
Akorn fights to salvage Fresenius deal in appeal to Delaware Supreme Court
Fierce Pharma
Akorn
Fresenius
M&A
Flag link:
Judge frees Fresenius from buyout, citing 'extensive and recurring' data problems at Akorn
Judge frees Fresenius from buyout, citing 'extensive and recurring' data problems at Akorn
Fierce Pharma
Akorn
Fresenius
M&A
Flag link:
Fresenius' $4.3B buyout of Akorn threatened by data integrity probe
Fresenius' $4.3B buyout of Akorn threatened by data integrity probe
Fierce Pharma
Fresenius
Akorn
drug manufacturing
generics
data integrity
FDA
Flag link:
Fresenius oncology drug plant slammed with new warning letter
Fresenius oncology drug plant slammed with new warning letter
Fierce Pharma
Fresenius
warnings
drug manufacturing
oncology
Flag link:
Fresenius closer and closer to marketing biosimilars
Fresenius closer and closer to marketing biosimilars
GoinPharma
Fresenius
biosimilars
Flag link:
Open plan designs: The good, the bad and the ugly; Fresenius adding 400-plus staffers
Open plan designs: The good, the bad and the ugly; Fresenius adding 400-plus staffers
Endpoints
open plan offices
Fresenius
hirings
Flag link:
The 10 largest medtech employers – and what their workers really think
The 10 largest medtech employers – and what their workers really think
Medical Design and Outsourcing
devices
employees
Baxter
B. Braun
Boston Scientific
Cardinal Health
Essilor
Fresenius
GE Healthcare
Medtronic
Philips
Stryker
Flag link:
Fresenius closes Merck biosimilar biz purchase
Fresenius closes Merck biosimilar biz purchase
Drug Delivery Business News
Fresenius
Merck KGaA
biosimilars
M&A
Flag link:
NxStage Medical Acquired by Fresenius for $2 Billion
NxStage Medical Acquired by Fresenius for $2 Billion
TheStreet.com
Fresenius
NxStage Medical
M&A
dialysis
devices
Flag link:
How Trump’s First 100 Days Affected the Healthcare Industry
How Trump’s First 100 Days Affected the Healthcare Industry
Motley Fool
Donald Trump
Express Scripts
Anthem
insurers
Akorn
Fresenius
Flag link:
Fresenius Kabi picks up generic maker Akorn for $4.3B
Fresenius Kabi picks up generic maker Akorn for $4.3B
BioPharma Dive
M&A
generics
Fresenius
Akorn
Flag link:
Big Pharma has become a leader in the fight against the death penalty
Big Pharma has become a leader in the fight against the death penalty
Yahoo/Business Insider
Big Pharma
execution drugs
McKesson
Pfizer
Fresenius
West-Ward Pharmaceuticals
Flag link:
2 firms seek to prevent drugs' use in Arkansas executions
2 firms seek to prevent drugs' use in Arkansas executions
Yahoo/AP
Arkansas
execution drugs
Pfizer
Fresenius
West-Ward Pharmaceuticals
Flag link:
Generics maker Akorn jumps on Fresenius takeout talks
Generics maker Akorn jumps on Fresenius takeout talks
BioPharma Dive
generics
Akorn
Fresenius
M&A
Flag link:
Fresenius Is Leading Bidder for Pfizer’s Pumps Business
Fresenius Is Leading Bidder for Pfizer’s Pumps Business
Bloomberg
Fresenius
Pfizer
devices
M&A
Flag link:
Fresenius CEO says to sit out healthcare deal wave
Fresenius CEO says to sit out healthcare deal wave
Yahoo/Reuters
Fresenius
M&A
Flag link:
Fresenius set to walk away from Danone unit - sources
Fresenius set to walk away from Danone unit - sources
Reuters
Fresenius
Danone
medical nutrition
M&A
Flag link:
Exclusive: Fresenius, buyout groups eye Danone Medical Nutrition unit - sources
Exclusive: Fresenius, buyout groups eye Danone Medical Nutrition unit - sources
Yahoo/Reuters
Fresenius
Danone
medical nutrition
M&A
Flag link:
Nestle and Fresenius home in on Danone Medical - sources
Nestle and Fresenius home in on Danone Medical - sources
Yahoo/Reuters
Nestle
Fresenius
Danone
M&A
Flag link:

Pages